AT Bancorp’s Array Biopharma Inc ARRY Stock Holding History

AT Bancorp’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-42,276	Closed	-$643K	–	236
2018 Q3	$643K	Buy	+42,276	New	+$648K	0.07%	137

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AT Bancorp's ARRY Position: Q4 2018 in Review

AT Bancorp sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 42,276 shares — an estimated $643K sold.

AT Bancorp first reported a position in ARRY in Q3 2018 and held it in 1 quarter. The position peaked at $643K in Q3 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

AT Bancorp reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
AT Bancorp sold 42,276 Array Biopharma Inc shares in Q4 2018, an estimated $643K.
AT Bancorp first reported a position in Array Biopharma Inc in Q3 2018 and held it in 1 quarter.
AT Bancorp's Array Biopharma Inc position peaked at $643K in Q3 2018.
236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on AT Bancorp's 13F filing for Q4 2018, filed 14 Feb 2019.